The future of left ventricular assist devices
- PMID: 26793340
- PMCID: PMC4703685
- DOI: 10.3978/j.issn.2072-1439.2015.11.01
The future of left ventricular assist devices
Abstract
The widespread acceptance of left ventricular assist device (LVAD) implantation in the treatment of heart failure has revolutionized the way end stage heart failure is treated. Advances in LVAD technology combined with a better understanding of patient selection has led to unparalleled survival as well as a reduction in the adverse event profile of these pumps. As our understanding of heart failure continues to grow, there is little doubt that LVADs will continue to play a pivotal role as a therapeutic option for those suffering from heart failure.
Keywords: Left ventricular assist device (LVAD); mechanical circulatory support (MCS).
Conflict of interest statement
Figures


References
-
- Kantrowitz A, Tjonneland S, Freed PS, et al. Initial clinical experience with intraaortic balloon pumping in cardiogenic shock. JAMA 1968;203:113-8. - PubMed
-
- Kilic A, Ailawadi G. Left ventricular assist devices in heart failure. Expert Rev Cardiovasc Ther 2012;10:649-56. - PubMed
-
- Barnard CN. The operation. A human cardiac transplant: An interim report of a successful operation performed at Groote Schuur Hospital, Cape Town. S Afr Med J 1967;41:1271-4. - PubMed
-
- Rose EA, Gelijns AC, Moskowitz AJ, et al. Long-term use of a left ventricular assist device for end-stage heart failure. N Engl J Med 2001;345:1435-43. - PubMed
-
- Kirklin JK, Naftel DC, Pagani FD, et al. Sixth INTERMACS annual report: A 10,000-patient database. J Heart Lung Transplant 2014;33:555-64. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Research Materials